Aquestive Therapeutics AQST

$ 5.15 0.0%

Quarterly report 2024-Q3
added 11-04-2024

Aquestive Therapeutics Balance Sheet 2011-2024 | AQST

Annual Balance Sheet Aquestive Therapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	21.5 M	6.43 M	-25.2 M	5.1 M	11 M	-13.4 M	28.1 M	29.4 M	-	-	-	-	-
Long Term Debt	45 M	33.4 M	1.95 M	34.3 M	60.3 M	42.6 M	45.5 M	38.6 M	-	-	-	-	-
Long Term Debt Current	390 K	255 K	899 K	728 K	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	90.3 M	66 M	43.8 M	54.3 M	46.2 M	-	-	-	-	-
Total Current Liabilities	18.3 M	39.5 M	22 M	21.1 M	18.6 M	33 M	-	-	-	-	-	-	-
Total Liabilities	164 M	176 M	144 M	111 M	84.6 M	76.8 M	69.6 M	57 M	-	-	-	-	-
Deferred Revenue	1.55 M	1.51 M	765 K	693 K	806 K	721 K	1.35 M	802 K	-	-	-	-	-
Retained Earnings	-319 M	-311 M	-257 M	-186 M	-130 M	-61.4 M	-120 M	-109 M	-	-	-	-	-
Total Assets	57.4 M	57.1 M	62 M	62.9 M	78.5 M	86.9 M	43.1 M	39.4 M	-	-	-	-	-
Cash and Cash Equivalents	23.9 M	27.3 M	28 M	31.8 M	49.3 M	60.6 M	-	-	-	-	-	-	-
Book Value	-106 M	-119 M	-82.1 M	-48.5 M	-6.12 M	10.1 M	-26.5 M	-17.6 M	-	-	-	-	-
Total Shareholders Equity	-106 M	-119 M	-82.1 M	-48.5 M	-6.12 M	10.1 M	-68.6 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Aquestive Therapeutics

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	45 M	45 M	45 M	14.8 M	39 M	39 M	42.4 M	5.08 M	51.5 M	-	51.5 M	1.95 M	51.5 M	51.5 M	51.5 M	51.5 M	70 M	70 M	70 M	70 M	70 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	155 M	153 M	166 M	164 M	162 M	164 M	171 M	176 M	160 M	-	150 M	144 M	126 M	121 M	114 M	111 M	111 M	111 M	111 M	84.6 M	84.6 M	84.6 M	84.6 M	76.8 M	76.8 M	76.8 M	76.8 M	69.6 M	69.6 M	69.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	1.05 M	1.05 M	1.55 M	1.55 M	2.64 M	3.99 M	4.76 M	1.51 M	774 K	-	1.6 M	765 K	767 K	642 K	437 K	693 K	693 K	693 K	693 K	806 K	806 K	806 K	806 K	721 K	721 K	721 K	721 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-346 M	-335 M	-332 M	-319 M	-311 M	-309 M	-303 M	-311 M	-299 M	-	-270 M	-257 M	-228 M	-213 M	-201 M	-186 M	-186 M	-186 M	-186 M	-130 M	-130 M	-130 M	-130 M	-61.4 M	-61.4 M	-61.4 M	-61.4 M	-120 M	-120 M	-120 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	110 M	118 M	130 M	57.4 M	59.4 M	57 M	61.3 M	57.1 M	51.8 M	-	56.5 M	62 M	65.3 M	66.9 M	61.9 M	62.9 M	62.9 M	62.9 M	62.9 M	78.5 M	78.5 M	78.5 M	78.5 M	86.9 M	86.9 M	86.9 M	86.9 M	43.1 M	43.1 M	43.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	77.9 M	89.9 M	95.2 M	23.9 M	24.9 M	22.4 M	26.9 M	27.3 M	18.6 M	17.7 M	14.7 M	28 M	31.2 M	34.2 M	27.5 M	31.8 M	17.1 M	31.8 M	31.8 M	49.3 M	49.3 M	49.3 M	49.3 M	60.6 M	60.6 M	60.6 M	60.6 M	17.4 M	17.4 M	17.4 M	-	9.21 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-45.4 M	-35.5 M	-36.3 M	-106 M	-103 M	-107 M	-109 M	-119 M	-108 M	-	-93.1 M	-82.1 M	-60.3 M	-53.8 M	-51.8 M	-48.5 M	-48.5 M	-48.5 M	-48.5 M	-6.12 M	-6.12 M	-6.12 M	-6.12 M	10.1 M	10.1 M	10.1 M	10.1 M	-26.5 M	-26.5 M	-26.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-45.4 M	-35.5 M	-36.3 M	-106 M	-103 M	-107 M	-109 M	-119 M	-108 M	-96.4 M	-93.1 M	-82.1 M	-60.3 M	-53.8 M	-51.8 M	-48.5 M	-48.5 M	-48.5 M	-48.5 M	-6.12 M	-6.12 M	-6.12 M	-6.12 M	10.1 M	10.1 M	10.1 M	10.1 M	-26.5 M	-68.6 M	-68.6 M	-	-57.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency